NASDAQ:JAGX Jaguar Animal Health Q3 2026 Earnings Results & Report $0.42 0.00 (0.00%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$0.40 -0.02 (-4.73%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Jaguar Animal Health beat analyst earnings expectations but missed on revenue in its Q3 2026 results, released November 16, 2026. The company reported EPS of -$9.23 versus the -$444.2941 consensus estimate, while revenue of $2.34 million fell short of the $4.85 million estimate by $2.51 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 16, 2026TimeBefore Market OpensConference Call DateNovember 17, 2026Conference Call8:30 AM ET Jaguar Animal Health EPS ResultsActual EPS-$9.23Consensus EPS -$444.2941Beat/MissBeat by +$435.0641One Year Ago EPSN/AJaguar Animal Health Revenue ResultsActual Revenue$2.34 millionExpected Revenue$4.85 millionBeat/MissMissed by -$2.51 millionYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Jaguar Animal Health Q3 2026 Earnings FAQ Did Jaguar Animal Health beat earnings estimates for Q3 2026? Jaguar Animal Health (NASDAQ:JAGX) reported earnings of -$9.23 per share for Q3 2026, beating the consensus estimate of -$444.2941. The report was announced on Monday, November 16, 2026. What was Jaguar Animal Health's revenue for Q3 2026? Jaguar Animal Health reported revenue of $2.34 million for Q3 2026, against a consensus estimate of $4.85 million. Jaguar Animal Health Earnings HeadlinesJaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate UpdatesNovember 13 at 12:26 PM | usatoday.comJaguar Animal Health (JAGX) Projected to Announce Quarterly Earnings on ThursdayNovember 5, 2026 | americanbankingnews.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 16 at 1:00 AM | Weiss Ratings (Ad)Napo Pharmaceuticals provides recap of panel discussionNovember 2, 2026 | tipranks.comCSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference ...November 2, 2026 | theglobeandmail.comJaguar Health, Inc.(BOIN:) dropped from S&P TMI IndexNovember 1, 2026 | marketscreener.comMSee More Jaguar Animal Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Jaguar Animal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jaguar Animal Health and other key companies, straight to your email. Email Address About Jaguar Animal HealthJaguar Health, Inc., formerly Jaguar Animal Health (NASDAQ:JAGX), develops prescription medicines for gastrointestinal disorders in humans and animals. The company’s research has focused on plant-derived compounds, including crofelemer, which is derived from the Croton lechleri tree. Jaguar’s animal-health product Canalevia-CA1 received FDA conditional approval for the treatment of chemotherapy-induced diarrhea in dogs. The company also develops and commercializes crofelemer-based medicines for human gastrointestinal conditions. Jaguar expanded beyond its original animal-health focus through its 2017 merger with Napo Pharmaceuticals, a company developing plant-based medicines for human health. Napo became a Jaguar subsidiary, and the combined company adopted the Jaguar Health name.View Jaguar Animal Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/13Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCerebras Q3 Results: How Much More Proof Does Wall Street Need?Applied Materials Beats and Raises, But Investors Stay Unconvinced3 Power and Grid Stocks That Could Keep Growing Even if AI Spending SlowsYETI Beat on Earnings, But Its Sales Tell a Different Story Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.